Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Cholinesterases and the pathology of Alzheimer disease.

Geula C, Mesulam MM.

Alzheimer Dis Assoc Disord. 1995;9 Suppl 2:23-8.

PMID:
8534419
2.
3.
5.
6.

Rivastigmine is a potent inhibitor of acetyl- and butyrylcholinesterase in Alzheimer's plaques and tangles.

Eskander MF, Nagykery NG, Leung EY, Khelghati B, Geula C.

Brain Res. 2005 Oct 26;1060(1-2):144-52. Epub 2005 Oct 5.

PMID:
16212945
7.
8.

Biochemical and histochemical comparison of cholinesterases in normal and Alzheimer brain tissues.

Darvesh S, Reid GA, Martin E.

Curr Alzheimer Res. 2010 Aug;7(5):386-400.

PMID:
19939227
9.
10.

Cholinesterases: new roles in brain function and in Alzheimer's disease.

Giacobini E.

Neurochem Res. 2003 Apr;28(3-4):515-22. Review.

PMID:
12675140
11.

Electron microscopic localization of cholinesterase activity in Alzheimer brain tissue.

Carson KA, Geula C, Mesulam MM.

Brain Res. 1991 Feb 1;540(1-2):204-8.

PMID:
2054612
12.

Changes in brain cholinesterases in senile dementia of Alzheimer type.

Perry EK, Perry RH, Blessed G, Tomlinson BE.

Neuropathol Appl Neurobiol. 1978 Jul-Aug;4(4):273-7.

PMID:
703927
13.

Acetylcholinesterase-rich pyramidal neurons in Alzheimer's disease.

Heckers S, Geula C, Mesulam MM.

Neurobiol Aging. 1992 Jul-Aug;13(4):455-60.

PMID:
1508295
14.
15.

Special properties of cholinesterases in the cerebral cortex of Alzheimer's disease.

Geula C, Mesulam M.

Brain Res. 1989 Sep 25;498(1):185-9.

PMID:
2790472
16.
17.

Neurofibrillary tangles have no obligatory predilection for acetylcholinesterase-rich neurons.

Mesulam MM, Brimijoin S, Geula C.

Neurobiol Aging. 1994 Sep-Oct;15(5):615-9.

PMID:
7824053
18.
19.

Cholinesterases in the amyloid angiopathy of Alzheimer's disease.

Mesulam M, Carson K, Price B, Geula C.

Ann Neurol. 1992 May;31(5):565-9.

PMID:
1375822
20.

Supplemental Content

Support Center